MENU
RVTY
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

RVTY stock forecast, quote, news & analysis

Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer... Show more

RVTY
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for RVTY with price predictions
Sep 15, 2026

RVTY's RSI Oscillator ascending into overbought territory

The RSI Indicator for RVTY moved into overbought territory on September 15, 2026. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RVTY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.

RVTY broke above its upper Bollinger Band on September 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 47 of 68 cases where RVTY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.

The Momentum Indicator moved above the 0 level on September 15, 2026. You may want to consider a long position or call options on RVTY as a result. In 66 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.

The Moving Average Convergence Divergence (MACD) for RVTY just turned positive on September 15, 2026. Looking at past instances where RVTY's MACD turned positive, the stock continued to rise in 32 of 48 cases over the following month. The odds of a continued upward trend are 67%.

Following a +12.78% 3-day Advance, the price is estimated to grow further. Considering data from situations where RVTY advanced for three days, in 197 of 299 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

The Aroon Indicator entered an Uptrend today. In 87 of 161 cases where RVTY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 54%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 8 (best 1 - 100 worst), indicating outstanding price growth. RVTY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.164) is normal, around the industry mean (60.424). P/E Ratio (67.399) is within average values for comparable stocks, (158.334). Projected Growth (PEG Ratio) (0.734) is also within normal values, averaging (1.549). RVTY has a moderately low Dividend Yield (0.002) as compared to the industry average of (0.007). P/S Ratio (5.441) is also within normal values, averaging (9.978).

The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RVTY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

A.I.Advisor
published Dividends

RVTY paid dividends on August 07, 2026

Revvity RVTY Stock Dividends
А dividend of $0.07 per share was paid with a record date of August 07, 2026, and an ex-dividend date of July 17, 2026. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are IQVIA Holdings (NYSE:IQV), Illumina (NASDAQ:ILMN), Guardant Health (NASDAQ:GH), Adaptive Biotechnologies Corp (NASDAQ:ADPT).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 19.34B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 2%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was 45%. MYGN experienced the highest price growth at 22%, while BIAF experienced the biggest fall at -29%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was 22%. For the same stocks of the Industry, the average monthly volume growth was -83% and the average quarterly volume growth was -2%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 60
Price Growth Rating: 41
SMR Rating: 78
Profit Risk Rating: 90
Seasonality Score: -20 (-100 ... +100)
View a ticker or compare two or three
RVTY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a manufacturer of analytical instruments

Industry MedicalSpecialties

Profile
Details
Industry
Medical Specialties
Address
77 4th Avenue
Phone
+1 781 663-6900
Employees
11000
Web
https://www.revvity.com
RVTY's RSI Oscillator ascending into overbought territory